Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Lymphome indolent")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 130

  • Page / 6
Export

Selection :

  • and

Purine analogue combinations for indolent lymphomasDI BELLA, Nicholas; RAVANDI, Farhad.Seminars in hematology. 2006, Vol 43, Num 2, issn 0037-1963, S11-S21, SUP2Conference Paper

Indolent Lymphomas of Mature B LymphocytesKURTIN, Paul J.Hematology/oncology clinics of North America. 2009, Vol 23, Num 4, issn 0889-8588, vii, 769-790 [23 p.]Article

New treatment approaches to indolent non-Hodgkin's lymphomaSEYMOUR, John F.Seminars in oncology. 2004, Vol 31, pp 27-32, issn 0093-7754, 6 p., SUP2Article

Management of indolent lymphoma: Where are we now and where are we goingLUNNING, Matthew A; VOSE, Julie M.Blood reviews. 2012, Vol 26, Num 6, pp 279-288, issn 0268-960X, 10 p.Article

Transformation of Indolent B-Cell LymphomasMONTOTO, Silvia; FITZGIBBON, Jude.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1827-1834, issn 0732-183X, 8 p.Article

Advances in molecular biology diagnostic and treatment of B-cell malignancies : indolent B-cell lymphomaDREYLING, M; BUSKE, C; HIDDEMANN, W et al.Annals of oncology. 2005, Vol 16, pp ii99-ii104, issn 0923-7534, SUP2Conference Paper

Traitement des lymphomes indolentsCHARBONNIER, N.Correspondances en onco-hématologie. 2012, Vol 7, Num 3, pp 5-9, issn 1954-4820, 5 p., SUP2Article

Standard approaches to relapsed indolent non-Hodgkin's lymphomaWITZIG, Thomas E.Seminars in hematology. 2007, Vol 44, Num 3, issn 0037-1963, S12-S17, SUP4Article

Lymphome indolent de l'oreille = Indolent lymphoma of the earVALOIS, A; BASTIEN, C; GRANEL-BROCA, F et al.Annales de dermatologie et de vénéréologie. 2012, Vol 139, Num 12, pp 818-823, issn 0151-9638, 6 p.Article

The peripheral helper T-cell repertoire in untreated indolent B-cell lymphomas : evidence for antigen-driven lymphomagenesisCHRISTOPOULOS, P; FOLIO, M; FISCH, P et al.Leukemia. 2008, Vol 22, Num 10, pp 1952-1954, issn 0887-6924, 3 p.Article

Place de l'association de l'anticorps monoclonal anti-CD20 avec les agents immunomodulateurs = Role of anti-CD20 monoclonal antibody in association with immunomodulatory agentsBOSLY, A.Pathologie et biologie. 2004, Vol 52, Num 1, pp 39-42, issn 0369-8114, 4 p.Article

Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphomaDI BELLA, Nicholas; TAETLE, Raymond; VUKELJA, Svetislava J et al.Blood. 2010, Vol 115, Num 3, pp 475-480, issn 0006-4971, 6 p.Article

Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-hodgkin lymphomaOKI, Yasuhiro; MCLAUGHLIN, Peter; FAYAD, Luis E et al.Cancer. 2007, Vol 109, Num 1, pp 77-83, issn 0008-543X, 7 p.Article

Phase II trial of idiotype vaccination in previously treated patients with indolent non-hodgkin's lymphoma resulting in durable clinical responsesREDFERN, Charles H; GUTHRIE, Troy H; ROSENFELT, Fred P et al.Journal of clinical oncology. 2006, Vol 24, Num 19, pp 3107-3112, issn 0732-183X, 6 p.Article

Indolent lymphoma: the pathologist's viewpointPILERI, S. A; ZINZANI, P. L; WENT, P et al.Annals of oncology. 2004, Vol 15, Num 1, pp 12-18, issn 0923-7534, 7 p.Article

Rituximab in Indolent LymphomasSOUSOU, Tarek; FRIEDBERG, Jonathan.Seminars in hematology. 2010, Vol 47, Num 2, pp 133-142, issn 0037-1963, 10 p.Article

Antibody and Immunomodulatory Agents in the Treatment of Indolent Non-Hodgkin's LymphomaLACASCE, Ann S; FREEDMAN, Arnold S.Seminars in hematology. 2008, Vol 45, Num 2, pp 85-89, issn 0037-1963, 5 p.Article

High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma : A study using patients as their own controlsVIGNOT, Stéphane; MOUNIER, Nicolas; LARGHERO, Jérome et al.Cancer. 2007, Vol 109, Num 1, pp 60-67, issn 0008-543X, 8 p.Conference Paper

An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorderQIN HUANG; CHANG, Karen L; GAAL, Karl K et al.The American journal of surgical pathology. 2005, Vol 29, Num 11, pp 1540-1543, issn 0147-5185, 4 p.Article

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissueZUCCA, Emanuele; CONCONI, Annarita; GIARDINI, Roberto et al.Blood. 2003, Vol 101, Num 7, pp 2489-2495, issn 0006-4971, 7 p.Article

Low dose 2-CdA schedule activity in Splenic Marginal Zone LymphomasRICCIONI, R; CARACCIOLO, F; GALIMBERTI, S et al.Hematological oncology. 2003, Vol 21, Num 4, pp 163-168, issn 0278-0232, 6 p.Article

Serum nm23-H1 protein as a prognostic factor for indolent non-hodgkin's lymphomaNIITSU, N; OKAMOTO, M; OKABE-KADO, J et al.Leukemia. 2001, Vol 15, Num 5, pp 832-839, issn 0887-6924Article

Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphomaNAVARRETE, Marcelo A; HEINING-MIKESCH, Kristina; SCHÜLER, Frank et al.Blood. 2011, Vol 117, Num 5, pp 1483-1491, issn 0006-4971, 9 p.Article

Long-term study of indolent adult T-cell leukemia-lymphomaTAKASAKI, Yumi; IWANAGA, Masako; TOMONAGA, Masao et al.Blood. 2010, Vol 115, Num 22, pp 4337-4343, issn 0006-4971, 7 p.Article

Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: Results of a prospective randomized trial of the German Low Grade Lymphoma Study GroupLENZ, Georg; DREYLING, Martin; SCHIEGNITZ, Eva et al.Journal of clinical oncology. 2004, Vol 22, Num 24, pp 4926-4933, issn 0732-183X, 8 p.Article

  • Page / 6